Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (81-90 of 284) with videos related to

Pageof 29
Sort By:
Cancer|November 7, 2000
Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphomaB Granel, J Serratrice, L Swiader, et al.
Blood|August 15, 1995
Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT GroupM Attal, D Blaise, G Marit, et al.
Blood|September 15, 1990
Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantationD Blaise, D Olive, A M Stoppa, et al.
Bone Marrow Transplantation|August 1, 1992
Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infectionsD Blaise, A M Stoppa, P Viens, et al.
Bone Marrow Transplantation|July 1, 1995
Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantationR Costello, D Blaise, J Jacquemier, et al.
Bulletin Du Cancer|August 1, 1996
[Contamination of cytapheresis by tumor cells: apropos of 39 breast cancer cases]M J Mozziconacci, C Arnoulet, G Novakovitch, et al.
Bone Marrow Transplantation|July 9, 2009
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantationP Chevallier, T Prebet, P Turlure, et al.
Bone Marrow Transplantation|July 20, 2002
Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patientsJ-O Bay, J Fleury, B Choufi, et al.
Bone Marrow Transplantation|June 1, 1997
Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantationS Oziel-Taieb, C Faucher-Barbey, C Chabannon, et al.
Leukemia|October 26, 2002
Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemiaM Mohty, D Isnardon, D Blaise, et al.
Pageof 29

Showing results (81-90 of 284) with videos related to

Sort By:
Pageof 29
Cancer|November 7, 2000
Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphomaB Granel, J Serratrice, L Swiader, et al.
Blood|August 15, 1995
Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT GroupM Attal, D Blaise, G Marit, et al.
Blood|September 15, 1990
Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantationD Blaise, D Olive, A M Stoppa, et al.
Bone Marrow Transplantation|August 1, 1992
Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infectionsD Blaise, A M Stoppa, P Viens, et al.
Bone Marrow Transplantation|July 1, 1995
Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantationR Costello, D Blaise, J Jacquemier, et al.
Bulletin Du Cancer|August 1, 1996
[Contamination of cytapheresis by tumor cells: apropos of 39 breast cancer cases]M J Mozziconacci, C Arnoulet, G Novakovitch, et al.
Bone Marrow Transplantation|July 9, 2009
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantationP Chevallier, T Prebet, P Turlure, et al.
Bone Marrow Transplantation|July 20, 2002
Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patientsJ-O Bay, J Fleury, B Choufi, et al.
Bone Marrow Transplantation|June 1, 1997
Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantationS Oziel-Taieb, C Faucher-Barbey, C Chabannon, et al.
Leukemia|October 26, 2002
Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemiaM Mohty, D Isnardon, D Blaise, et al.
Pageof 29